| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 46.996 | 53.927 | 59.865 | 41.294 | 49.890 | 38.805 | 69.225 | 68.605 | 76.911 | 35.660 |
| Total Income - EUR | 46.996 | 53.927 | 59.865 | 41.294 | 49.890 | 40.587 | 69.240 | 68.607 | 76.916 | 113.239 |
| Total Expenses - EUR | 23.107 | 34.216 | 40.273 | 43.375 | 47.774 | 29.950 | 38.077 | 40.601 | 47.500 | 109.338 |
| Gross Profit/Loss - EUR | 23.889 | 19.711 | 19.592 | -2.081 | 2.117 | 10.637 | 31.163 | 28.006 | 29.416 | 3.901 |
| Net Profit/Loss - EUR | 22.479 | 19.074 | 18.993 | -2.492 | 1.618 | 10.412 | 30.553 | 27.423 | 28.685 | -8.103 |
| Employees | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oftaclinic-Optic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.034 | 110.655 | 107.559 | 101.651 | 96.057 | 90.268 | 84.892 | 81.770 | 78.147 | 0 |
| Current Assets | 26.725 | 9.299 | 11.826 | 7.113 | 4.891 | 14.107 | 16.280 | 8.327 | 20.734 | 84.219 |
| Inventories | 634 | 1.722 | 3.166 | 3.337 | 1.959 | 2.381 | 2.637 | 3.238 | 3.370 | 619 |
| Receivables | 222 | 232 | 77 | 6 | 8 | 501 | 29 | 262 | 12.843 | 27.248 |
| Cash | 25.868 | 7.345 | 8.584 | 3.770 | 2.924 | 11.224 | 13.615 | 4.827 | 4.521 | 56.352 |
| Shareholders Funds | 23.722 | 19.344 | 19.258 | 16.413 | 17.713 | 27.789 | 57.726 | 85.328 | 92.527 | 53.752 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.074 | 100.611 | 100.175 | 92.392 | 83.255 | 76.590 | 43.446 | 4.769 | 6.353 | 30.467 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Oftaclinic-Optic Srl